Vanguard Group’s Comera Life Sciences Holdings, Inc. Common Stock CMRA Stock Holding History

Vanguard Group’s Portfolio CMRA Stock Details CMRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-44,098	Closed	-$12.9K	–	4555
2023 Q3	$12.9K	Hold	44,098	–	–	﹤0.01%	4516
2023 Q2	$21.5K	Hold	44,098	–	–	﹤0.01%	4514
2023 Q1	$39.6K	Buy	44,098 +100	+0.2%	+$126	﹤0.01%	4491
2022 Q4	$54.1K	Buy	+43,998	New	+$64.3K	﹤0.01%	4439

Vanguard Group's CMRA Position: Q4 2023 in Review

Vanguard Group sold out of Comera Life Sciences Holdings, Inc. Common Stock (CMRA) in Q4 2023, closing a stake of 44,098 shares — an estimated $12.9K sold.

Vanguard Group first reported a position in CMRA in Q4 2022 and held it in 4 quarters. The position peaked at $54.1K in Q4 2022. 0 funds tracked by Wall St. Rank hold CMRA as of Q4 2023.

Vanguard Group reported no remaining Comera Life Sciences Holdings, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Vanguard Group sold 44,098 Comera Life Sciences Holdings, Inc. Common Stock shares in Q4 2023, an estimated $12.9K.
Vanguard Group first reported a position in Comera Life Sciences Holdings, Inc. Common Stock in Q4 2022 and held it in 4 quarters.
Vanguard Group's Comera Life Sciences Holdings, Inc. Common Stock position peaked at $54.1K in Q4 2022.
0 funds tracked by Wall St. Rank held Comera Life Sciences Holdings, Inc. Common Stock as of Q4 2023.

Based on Vanguard Group's 13F filing for Q4 2023, filed 14 Feb 2024.